Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

Clinical trial NCT00178841 · COMPLETED

Trial details

NCT number: NCT00178841
Sponsor: Vanderbilt University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma Mycosis Fungoides Sezary Syndrome

Start date: 2005-06-01
Primary completion: 2007-03-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.